Stomach Neoplasms D013274

Related MeSH Hierarchy (4)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Stomach Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Stomach Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Stomach Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Stomach Diseases » Stomach Neoplasms

Description

Tumors or cancer of the STOMACH.   MeSH

Hierarchy View


Approved Indicated Drugs (2)

Phase 3 Indicated Drugs (95)

Phase 2 Indicated Drugs (200)

Phase 1 Indicated Drugs (166)


Organization Involved with Phase 3 Indications (183)

Organization Involved with Phase 2 Indications (255)

Academic and Community Cancer Research United

ACT Biotech, Inc

AIO-Studien-gGmbH

Altor Bioscience

Arbeitsgemeinschaft medikamentoese Tumortherapie

Aristotle University of Thessaloniki

ArQule

Astellas

Astex Pharmaceuticals, Inc.

Aventis

Bayer

B. Braun

Beijing Biohealthcare Biotechnology Co.,Ltd

Beijing Doing Biomedical Co., Ltd.

Bengbu Medical College

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Bicycle Therapeutics

Binex

Boehringer Ingelheim

Boston University

Breast Cancer Now

Brown University

Burzynski Research Institute

Cancer Therapeutics Research Group

Cancer Trials Ireland

Case Western Reserve University

Cato Research

Celgene

Celltrion

Central South University

Centre Georges Francois Leclerc

Centre Hospitalier La Source, Orleans

Centre Hospitalier Universitaire Vaudois

Centre Leon Berard

Chang Gung University

Chao Family Comprehensive Cancer Center

ChapelPharma Ltd

China Medical University

Chiron

Chongqing Precision Biotech Co., Ltd

CHR Annecy

CHU Besançon

CHU Morvan

City of Hope National Medical Center

City University of Hong Kong

Clinical Study Support, Inc.

Clovis Oncology

Columbia University

Cornell University

Cure&Sure Biotech Co., LTD

Curie Institute

Desert Regional Comprehensive Cancer Center

Duke University

Eastern Cooperative Oncology Group

Eastern Hepatobiliary Surgery Hospital

EddingPharm Oncology Co., LTD.

Eindhoven Cancer Registry

Eisai

Emory University

Enzon

Epidemiological and Clinical Research Information Network

ExcellaBio LLC

Far Eastern Memorial Hospital

FeRx

Fiverings Co., Ltd.

Food and Drug Administration

Fukushima Medical University

Genta

Georgetown University

Government of China

Government of Singapore

Government of Taiwan

Groupe Hospitalier Paris Saint Joseph

Gruppo Oncologico Italiano di Ricerca Clinica

Guangzhou University

GWT-TUD GmbH

Hanmi Pharmaceutical

Harbin Medical University

Hefei University

Hellenic Cooperative Oncology Group

Hellenic Oncology Research Group

Hokkaido University

Hospital A.C. Camargo

Icahn School of Medicine at Mount Sinai

Imclone

ImmunogenX

Incyte

Institut Bergonié

Institut de Cancerologie de l'Ouest Paul Papin

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Institut Gustave Roussy

Institut Mutualiste Montsouris

Instituto do Cancer do Estado de São Paulo

Institut Paoli-Calmettes

International Extranodal Lymphoma Study Group

Intima Bioscience, Inc.

Ioannina University Hospital

Ipsen

Jeil Pharmaceutical Co., Ltd.

Jeroen Bosch Ziekenhuis

Jilin Provincial Tumor Hospital

Jinan University

Jingzhou Central Hospital

Johannes Gutenburg University

Johns Hopkins University

Kangbuk Samsung Hospital

Keio University

Klus Pharma Inc.

Korea Institute of Radiological & Medical Sciences (KIRAMS)

Korean South West Oncology Group

Kyowa Hakko Kirin

Leap Therapeutics, Inc.

Ludwig Maximilians University

Mackay Medical College

Martin Luther University

Medical College of Wisconsin

Medical University of South Carolina

MedImmune

MedPacto, Inc.

Memorial Cancer Institute, Florida

Memorial Sloan-Kettering Cancer Center

Merrimack Pharmaceuticals

Nanobiotix

National Cancer Center, Japan

National Cheng Kung University

National Comprehensive Cancer Network

Nationales Centrum fur Tumorerkrankungen

National OncoVenture

National Taiwan University

National University of Singapore

Nebraska Cancer Specialists

Neovii Biotech

New York University

NextCure, Inc.

Ningbo Cancer Hospital

Ningbo No. 5 Hospital

NKMAX Co., Ltd.

Nordic Pharma Group

Northwell Health

Northwestern University

Norwegian University of Science and Technology

Ohio State University

Oncologie Inc.

Ospedale S. Giovanni Bellinzona

People's Hospital of Zhongshan

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Pharmacia & Upjohn

PharmaEngine

Piedmont Hospital

PPD

Qingdao Municipal Hospital

Qinghai University

Radiation Therapy Oncology Group

RemeGen

Rhode Island Hospital

R-Pharm

Ruhr University Bochum

Rutgers University

Sanofi-Synthelabo

SCRI Development Innovations

Seattle Integrative Cancer Center

Second Military Medical University

Shandong Provincial Hospital

Shandong Tumor Hospital

Shanghai Cell Therapy Research Institute

Shanghai Easter Hospital

Shanghai Junshi Bioscience Co.,Ltd.

Shanghai Sunstem Biotechnology Co., Ltd.

Shenzhen Hornetcorn Bio-technology Company, LTD

Shonan Kamakura Hospital

Sichuan University

Simcere Pharmaceutical Co., Ltd

Soochow University

Soonchunhyang University

Southwest Oncology Group

Sponsor GmbH

Stanford University

State University of New York, Buffalo

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

SWAN Isotopen AG, Bern

Taipei Veteran General hospital

Technical University of Dresden

Teclison Ltd.

Tel Aviv University

Tennessee Oncology, PLLC

Texas Oncology Cancer Center

The Catholic Medical Center

The Second People's Hospital of Sichuan

The University of Texas, Dallas

Translational Oncology Research International

Trinity College Dublin

Tsinghua University

Tularik

Universidad Autonoma de Barcelona

University of Alabama, Birmingham

University of Amsterdam

University of Angers

University of Arizona

University of Athens

University of Bern

University of Bordeaux

University of Caen-Normandie

University of California, Berkeley

University of California, Irvine

University of California, San Diego

University of California, San Francisco

University of Cantabria

University of Cincinnati

University of Copenhagen

University of Crete

University of Duisburg-Essen

University of Franche-Comté

University of Geneva

University of Glasgow

University of Hamburg

University of Kansas

University of Lausanne

University of Leicester

University of Lille

University of Liverpool

University of Lorraine

University of Medicine and Dentistry of New Jersey

University of Miami

University of Minnesota

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Pennsylvania

University of Pittsburgh

University of Rennes

University of Rochester

University of South Carolina

University of Southern California

University of South Florida

University of Texas, Galveston

University of Tokyo

University of Toronto

University of Turku

University of Vienna

University of Washington

Uppsala University

Vedanta Biosciences, Inc.

Wakayama Medical University

Wake Forest University

Washington University in St. Louis

Wayne State University

WiSP GmbH

Wuhan Union Hospital, China

Wuhan University

Xiamen University

Xiansheng Pharmaceutical Company

Xuzhou Medical University

Yale University

Yeshiva University

Zhejiang Chinese Medical University

Zhongnan Hospital

Organization Involved with Phase 1 Indications (64)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.